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Abstract
Many protein interaction domains bind short peptides based on canonical sequence consensus motifs. Here we report the
development of a peptide array-based proteomics tool to identify proteins directly interacting with ligand peptides from
cell lysates. Array-formatted bait peptides containing an amino acid-derived cross-linker are photo-induced to crosslink with
interacting proteins from lysates of interest. Indirect associations are removed by high stringency washes under denaturing
conditions. Covalently trapped proteins are subsequently identified by LC-MS/MS and screened by cluster analysis and
domain scanning. We apply this methodology to peptides with different proline-containing consensus sequences and show
successful identifications from brain lysates of known and novel proteins containing polyproline motif-binding domains
such as EH, EVH1, SH3, WW domains. These results suggest the capacity of arrayed peptide ligands to capture and
subsequently identify proteins by mass spectrometry is relatively broad and robust. Additionally, the approach is rapid and
applicable to cell or tissue fractions from any source, making the approach a flexible tool for initial protein-protein
interaction discovery.
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Introduction
Many regulatory proteins that govern cellular signaling events
adopt modular structures consisting of multiple domains [1,2].
These domains form independent, three-dimensional structures to
exert specialized functions within the cell [3]. The functionality of
these domains can be primarily divided into two major roles:
interactive and enzymatic. Interactive domains bind to proteins,
lipids or nucleotides and control the residing protein’s activity,
intracellular localization and stability [1]. Among the interactive
domains, many domains bind to short peptide ligands [4].
Characterization of the binding specificity has determined
consensus motifs in the target peptide sequences for many of
these domains [4]. Thus, it is now to some extent possible to
anticipate the class of domains that may bind to a certain peptide
with a consensus motif. However, it is still impracticable to predict
individual domains/proteins that actually interact with the peptide
in the cell since the specificity for the individual domains is
determined by amino acids not involved in the consensus motifs.
For instance, actin cytoskeletal regulatory proteins such as formin-
family proteins or Arp2/3-dependent actin nucleation promoting
factors (NPF) often have poly-proline sequences [5,6], but the
proteins that interact with these sequences are largely unknown.
Although it is expected that the poly-proline sequences may
interact with proteins with EH, EVH1, SH3, WW domains
[4,7,8,9], time consuming approaches are still required to identify
the specific proteins involved.
One of primary methodologies to identify signaling complexes
based on protein interactions is affinity purification (AP) followed
by mass spectrometry (MS) [10,11]. In this case, immobilized bait
proteins are incubated with cell/tissue lysates and, after extensive
washes to remove non-specific interactors, the binding partners are
identified by MS analysis. However, this approach has some
disadvantages: the extensive washing disrupts weak or transient
interactions, and no information is provided on which proteins are
direct interactors with the bait among the identified proteins.
Another strategy is the yeast two-hybrid (YTH) screen. This
method identifies direct interactions because the YTH is based on
bimolecular interactions to activate reporter gene transcription
[12]. There, however, are some limitations: the interactions have
to occur in the yeast nucleus, post-translational modifications on
the bait peptides/proteins that may occur in mammalian cells such
as phosphorylation are unlikely to be recapitulated within yeast,
and false positive rates can be high due to spurious transcriptional
activation by bait sequences. Moreover, both AP-MS and YTH
approaches are difficult to perform with large numbers of bait
targets due to the extensive optimization for individual proteins.
To circumvent several of these problems, we have developed
a peptide array-based cross-linking strategy. Here we report that
our strategy identifies both previously known and novel interac-
tions for peptides with different consensus motifs from brain tissue
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lysates. We also apply the method to a poly-proline sequence of
Wiskott-Aldrich syndrome protein family member 1 (WAVE1),
a member of WAVE/WASP family NPF proteins, and demon-
strate the identification of novel interacting proteins.
Results
PAX–Captured Proteins Are MS Identifiable
Benzophenone photoprobes, which covalently couple to un-
reactive C-H bonds upon exposure to 350–360 nm light, have
been widely used for biochemical characterization of macromo-
lecules since the 1980s [13,14]. More recently the benzophenone
phenylalanine derivative, p-benzoyl-L-phenylalanine (pBpa) has
been successfully translated into proteins of interest within cells,
enabling the photo-induced crosslinking of protein-protein inter-
actions as they occur in situ [15,16,17,18,19]. We have used this
approach to purify and discover new interactions by incorporating
pBpa into protein binding domains expressed within mammalian
cells [20]. The success of this approach prompted us to wonder if
the reverse strategy, utilizing peptides containing pBpa, could also
be useful for the rapid identification of protein interactions from
cell lysates. The primary obstacle to this approach is that pBpa
must be positionally placed within the peptide such that it is close
enough to capture a binding protein, but not within the binding
site so as to not disrupt the relevant interaction. This requirement
creates a problem, however, since permissive positions within
a putative peptide ligand are unknown for uncharacterized
interactions that are the target of protein interaction discovery
approaches. This problem could be circumvented, however, if the
peptide ligand is represented as an array of peptide sequences,
with pBpa placed at each possible position within the peptide
(Figure 1A and inset). In this format, potential interactions with the
peptide may be covalently captured by those peptides in which
pBpa is at a permissive position for binding and crosslinking,
without prior knowledge of which site is optimal. Previously we
have used the SPOT technology to synthesize arrays of peptide
sequences on PEG derivatized cellulose membranes [20,21,22].
384 peptides can be synthesized on a membrane within a 24616
spot format, and up to 4 membranes can be processed at a time.
We hypothesized that pBpa containing peptides arrayed in this
format, incubated with cell or tissue lysates, and exposed to UV
light in the 350–360 nm range might provide a convenient and
rapid approach to phototrap peptide-protein interactions. After
incubation with cell/tissue lysates of interest and photo-induced
covalent trapping of binding proteins (Figure 1B–C), the peptide
array can be extensively washed under denaturing conditions to
aid the removal of indirect and non-specific interactors (Figure 1D).
Peptides with bound proteins would then be trypsin digested and
analyzed by mass spectrometry (Figure 1E–H).
We first investigated if proteins photo-trapped to arrayed bait
peptides synthesized on cellulose membrane are identifiable by
mass spectrometry. The primary concern was whether enough
bound protein could be photo-trapped within the peptide spots to
be subsequently detected by mass spectrometry. For nanoscale
capillary UPLC columns typically used in LC-MS experiments,
optimal column loads between 500 ng and 1 ug of total protein
digest are desired. Since this direct-interactor only array cross-
linking experiment results in a much simplier composition of
proteins, column loads as low 100 ng would yield an appropriate
column load because the moles of each protein per amount of
input material would be significantly higher. As a test case, we
ectopically expressed SLIT-ROBO Rho GTPase-activating pro-
tein 2 (srGAP2) in FreeStyle 293 suspension cells whose SH3
domain is known to interact with a proline-rich sequence within
Formin-like protein 1 (FMNL1) [22]. Cell lysate from transfected
cells was incubated with FMNL1 poly-proline peptide arrays with
each of the peptide spots containing pBpa at a distinct position
(Fig. 2A). The membrane was subjected to UV light (365 nm) to
induce cross-linking and then washed extensively with a harsh
denaturing solution (0.1% Tween-20, 1% SDS, pH2.5, 95uC: See
Method for more details). Immunoblotting was then performed
using an anti-srGAP2 antibody, demonstrating that srGAP2 was
photo-trapped to the peptide spots on the membrane (Fig. 2A).
The amount of the captured srGAP2 varied, dependent on the
positions of pBpa within the bait peptide, indicating which amino
acids are critical for the interaction. Unexpectedly, the peptide
without pBpa also showed positive signal, suggesting this in-
teraction could survive the high stringent washes to a lesser extent.
Unrelated peptides did not capture any trace of srGAP2,
demonstrating the bound srGAP2 that was detected was specific.
To estimate the amounts of the captured srGAP2, we dot
blotted known concentrations of the srGAP2 antigen onto
nitrocelluse (Fig. 2B). The dot blot membrane was incubated with
anti-srGAP2 antibody solution together with the PAX membrane
mentioned above. Comparison of the signal strength revealed that
the strongest signals of the PAX blot captured an estimated 10–20
femtomoles of srGAP2, suggesting enough material may be
captured for MS analysis. This possibility was tested with the five
strongest peptide spots (equivalent to 50–100 femto moles) from
a duplicate membrane strip, which were cut into small pieces,
gathered in a tube, trypsinized, filtered through a spin column to
remove contaminating PEG, and applied to LC-MS/MS (Fig. 1).
MS analysis identified three unique peptides corresponding to the
srGAP2 protein, confirming prey proteins can be captured from
cell lysates for MS identification (Fig. 2C).
We next tested if PAX methodology could photo-trap endog-
enous proteins from brain lysates. Peptides from Metabotropic
glutamate receptor 5 (mGluR5) that are known to bind the class II
(Homer/Vesl proteins) EVH1 domain of a postsynaptic density
scaffolding protein Homer1 [23] were incubated with brain lysates
from adult mice and subjected to PAX. pBpa position-dependent
interactions were observed by immunoblotting using anti-Homer1
antibody (Fig. 2D). As expected, the replacement of the amino
acids of the consensus motif with pBpa abolished the interaction.
Interestingly, the replacement of acidic amino acids (Glu and Asp)
outside the motif also abolished the interaction, revealing
additional amino acids for the interaction that are indispensible.
PAX-MS Identifies Known and Novel Interactions from
Brain Lysates
To examine the applicability of PAX as a proteomics tool to
identify peptide-protein interactions, we applied PAX to several
peptide ligands with proline-containing motifs, including Son of
sevenless homolog 1 (SOS1), Stonin2, Epsin1 and mGluR5, each
of which has previously known binding partners (Table 1)
[23,24,25,26,27,28,29]. A negative control peptide without
homology (no more than 50% sequence identity to any
mammalian sequences) or proline-containing binding motifs was
used. All the bait peptides were synthesized in an array format on
the same membrane. Each bait consisted of 12 peptide spots, and
each of these peptides contained pBpa at different positions. The
membrane was incubated with mouse brain lysate made from two
adult brains, exposed to UV light to photo-trap interacting
proteins, washed at high stringency and cut off into individual bait
strips. Each strip was then trypsinized and subjected to MS
analysis to identify the photo-trapped proteins. This procedure was
performed in duplicate and identified a total of 198 proteins. To
minimize false positives, we used high stringency criteria [0.2%
Peptide Array Crosslinking for Proteomic Profiling
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protein and 4.9% peptide false discovery rates] for this MS
identification. In protein interaction studies, elimination of non-
specific interactions is critical. To extract high confidence
interactions, we performed two complimentary data analyses: (1)
identification of selective bait interactors, and (2) protein in-
teraction domain filtering.
First, to decode the association pattern of the MS-identified
proteins for each bait peptide, we performed cluster analysis using
Pearson correlation of the mean normalized spectral counts, which
are MS measurements that reflect the relative abundance of the
proteins in the PAX sample (Fig. 3A). In this analysis, we focused
only on the proteins that were associated with single bait peptides.
These interactions are of higher confidence because the interac-
tions with the other bait peptides function as negative controls and
proteins interacting with all peptides are likely to be non-specific.
The cluster analysis produced 4 protein clusters that showed
a specific association to each bait peptide for mGluR5, Epsin1,
Stonin2 and SOS1 (Fig. 3B). The mGluR5-specific cluster
contained Homer1, a known interactor of the mGluR5 peptide
(Table 1). The SOS1-specific cluster also contained GRB2,
a known interactor of the SOS1 peptide. We next performed
bioinformatics searches to see if there are any other known
interactions among the bait proteins and the corresponding
protein clusters (see the Method section). This search identified
another known interactor in the mGluR5 protein cluster (Homer3)
and 3 known interactors (Pacsin1, Sh3kbp1, Cd2ap) in the SOS1-
specific protein cluster. Thus, single bait interaction clusters
identified previously known interactions including our ‘‘positive
controls’’ from brain lysates. The rest of the interactors in the
clusters are previously-unidentified binding proteins and to verify
these interactions, additional assays such as co-immunoprecipita-
tion or co-localization experiments are required.
Clustering analysis is useful to identify higher confidence
interactions but has an obvious limitation; proteins that contain
domains, which may interact with related bait sequences are
excluded. An advantage to using peptide sequences as baits is that
it is possible to predict the type of protein interaction domain that
may bind to it. To capitalize on this, we utilized consensus binding
motifs found in the bait peptides to predict domains that should be
found within legitimate binding proteins. Table 1 describes
consensus binding motifs identified in the bait peptides and the
domains that are expected to bind these motifs. To filter the
interaction data by expected domains, we eliminated all the
proteins that showed association to the control peptide and
performed cluster analysis. We then filtered the data for proteins
containing the expected interaction domains. Thus all the proteins
that remained indicate high confidence interactions predicted to
bind to each bait peptide based on its primary sequence and the
corresponding interaction domains (Fig. 3C). This domain filtering
identified all the previously known interactions identified by the
cluster analysis, but also found potentially meaningful new
interactions that had previously been discarded (Fig. 3D). For
example, the domain filtering identified 3 other proteins that
interacted with multiple baits. Intersectin-1 (Itsn1) was positive for
SOS1, Stonin2 and Epsin1 because of its SH3 domain and EH
domain. The interactions with the SOS1 and Stonin2 peptides
were previously identified (Table 1), and thus the interactions with
Epsin1 are newly identified by the domain filtering. Epidermal
growth factor receptor substrate 15-like 1 (Eps15l1) remained
positive for Stonin2 and Epsin1 because of its EH domain. These
interactions were also previously identified (Table 1). Amphiphysin
(Amph) was positive for SOS1 and Epsin1 because of its SH3
domain. Amphiphysin2 (Amph2), highly homologous to Amph1, is
known to bind to the proline-rich region of SOS1 [30], indicating
Figure 1. Experimental outline of PAX methodology. (A) Arrays of bait peptides are synthesized onto PEG-based membrane supports. The
photo-activatable amino acid cross-linker (pBpa) is incorporated into the bait peptides so that each peptide spot has pBpa at a different position in
the sequence (see inset schematic). (B, C) The membrane is incubated with cell lysate and subjected to 350–365 nm light to cross-link with
interacting proteins. (D) The indirect and non-specific interactors are removed by high stringent, denaturing washes. (E, F) Each strip of the bait
peptide spots is cut off the membrane, further chopped into small pieces, and trypsinized. (G, H) The samples are filtered to remove PEG and
subjected to LC-MS/MS analysis to identify the photo-trapped proteins.
doi:10.1371/journal.pone.0037035.g001
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this newly identified interaction between SOS1 and Amph1 is
likely. Epsin1 was identified as a novel interactor. Thus the
domain filtering identified most of the expected and known
interactions. Combining the two analyses, we were able to select
10 high confidence interacting proteins (14 high confidence
interactions) out of 198 MS-identified interactors (544 possible
interactions).
PAX-MS Identifies Novel Interactions with WAVE1
We next applied the PAX and subsequent data analyses to the
proline-rich sequence of WAVE1, a member of the Arp2/3-
dependent actin nucleation promoting factors, to identify novel
interactions from mouse brain lysates. To apply the clustering
analysis, we combined MS data for WAVE1 with the previous MS
data obtained for SOS1, Stonin2, Epsin1 and mGluR5 to
elucidate WAVE1-specific protein cluster (Fig. 4A). The sub-
sequent bioinformatics analysis identified no previously known
Figure 2. PAX-captured proteins are MS identifiable. (A) PAX captures a known interacting protein following over-expression in FreeStyle 293
cells. An array of peptides consisting of a proline-rich sequence of FMNL1 and a control sequence were incubated with FreeStyle 293 cell lysate
overexpressing srGAP2, photo-crosslinked and washed at high stringency. Immunoblotting with srGAP2 antibody detected phototrapping of srGAP2
by PAX. pBpa in the bait peptides is indicated in blue. (B) Comparative immunoblotting of srGAP2 antigen dot-blot. Different amounts of srGAP2
were spotted onto nitrocellulose membrane and simultaneously immunoblotted with srGAP2 antibody. (C) Identification of srGAP2 by mass
spectrometry. The five spots with the highest amount of crosslinked srGAP2 from a duplicate blot of (A) were subjected to MS/MS. 3 unique peptides
(underlined) covering 8% of the entire sequence of srGAP2 protein were identified. (D) PAX captures a known interacting protein from mouse brain
lysate. Peptide array comprising mGluR5 sequences with a PPXXF motif was incubated with mouse brain lysate, photo-crosslinked and subjected to
high stringency washes. Immunoblotting with Homer1 antibody indicates photo-trapping of Homer1 by PAX. pBpa in the bait peptides is indicated
in blue.
doi:10.1371/journal.pone.0037035.g002
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interactors with WAVE1 but 2 plausible interactors, Vasodilator-
stimulated phosphoprotein (Vasp) and Growth arrest-specific
protein 7 (Gas7), that both have been revealed to interact with
highly homologous family members of WAVE1 (WAS and
WAVE2).
We next performed the domain filtering (Fig. 4B) and identified
a total of 13 proteins for the five different baits. We assessed the
abundance of proteins from the input brain lysate over a range of
approximately three orders of magnitude. Only three of the
proteins were identified (Pacsin1, Amph, and EHD) (Fig. 4C),
suggesting most of the interactions detected were from low
abundance proteins within the lysate. In comparison, analysis of
the negative control peptide interactions revealed the top 13
proteins, based on the percentage of total spectra, were all highly
abundant proteins. Twelve of these ranked within the top 100
abundant proteins of the lysate (EF1A1: #46, TBA1A/B: #8,
CN37: #75, CLH: #47, ACTB: #11, G3P: #5, KCRB: #14,
NSF: #95, SYN2: #93, TBB3: #37, KPYM: #23, TBB2B/C:
#7). For WAVE1, the same interactors (Vasp and Gas7) were
identified in the domain filtering analysis (Fig. 4D). Both the
proteins have one of the expected domains for the WAVE1 bait
peptide, WW and the class I (Ena/Vasp proteins) EVH1 proline
binding domains (Table 1). Domain filtering also identified 2 more
novel interactors, Amphiphysin (AMPH) and Enabled (Enah).
Interactions between the full-length proteins of WAVE1 and
Amphiphysin (Fig. 4E) and Gas7 (Fig. 4F) were confirmed by co-
expression and co-immunoprecipitation. Enah is a homolog of
Vasp but no interactions with WAVE/WASP family proteins have
been reported. We first determined whether the WAVE1 peptide
initially used as a bait would be sufficient to pulldown Enah from
cell extracts (Fig. 4G). GST fused WAVE1 proline peptide (GST-
Pro/WAVE1) weakly interacted with GFP-Enah, whereas GST
alone did not. To confirm and further characterize the interaction
between WAVE1 and Enah, we performed co-immunoprecipita-
tions with Flag-tagged full length WAVE1 or WAVE1 lacking the
proline peptide used as bait (WAVE1 DPro) and GFP-Enah
(Fig. 4H). WAVE1 and Enah readily co-precipitated when
compared to negative control immunopreciptations. Surprisingly,
Enah also co-precipitated with WAVE1 lacking the bait peptide
sequence. These results suggest that while the WAVE1 bait
peptide is sufficient to interact with Enah, other interactions also
participate in the binding reaction. We have previously noted
similar results with WRP, which also binds to the proline rich
region of WAVE1 in addition to other secondary interactions [31].
Reciprocal co-immunoprecipitation experiments were next per-
formed to determine if endogenous WAVE1 and Enah interact.
The interaction between the endogenous WAVE1 and Enah in
mouse brain extracts was validated (Fig. 4I). Ectopically expressed
GFP-tagged Enah also showed co-localization with endogenous
WAVE1 in mouse fibroblast cells, confirming their colocalization
cells (Fig. 4J and [32]). Together these data demonstrate the PAX
methodology and the data analyses can be a useful tool to rapidly
identify novel peptide-protein interactions from cell or tissue
lysates, including those involving lower abundance proteins.
Discussion
In the study of peptide recognition domains, phage display in
which diverse libraries of phage-derived peptide ligands are
exploited to determine the binding affinity and specificity for
a specific domain has been a powerful strategy [33]. The resulting
consensus binding peptide sequences can be utilized to bioinfor-
matically search for candidate ligand sequences in genomes and
these candidate peptides can be validated as ligands in subsequent
experiments [34,35,36]. This approach, however, is domain
centric and usually is biased towards identifying a large number
of candidate peptides for a limited number of domains.
In the present study, our goal was to identify interactions with
peptide ligands from the whole proteome of selected lysates. To
accomplish this we have developed a unique proteomics tool in
which peptide arrays are used as baits to isolate interacting
proteins from tissue lysates. We have demonstrated in a proof-of-
principle manner the mass spectrometry-based identification of
known and novel interacting proteins. This method allows for the
rapid identification of direct protein-peptide associations, based on
the covalent capturing of interactions via a photo-activatable
unnatural amino acid cross-linker incorporated into bait peptides.
The covalent fixation of direct interactors to the baits therefore
made possible the simple and efficient removal of indirect
associations by high stringency washes. In the present study, we
have applied this PAX method to bait peptides with various
proline-containing consensus motifs and demonstrated the MS-
based identification of interactions. We have also shown how two
independent data analyses: (1) cluster analyses to select single bait
interactors and (2) domain filtering successfully identified both
known and novel interactions.
The application of the methodology to the proline-rich
sequence of WAVE1 revealed 4 high confidence interactions.
One of the interactions between WAVE1 and Enah was further
confirmed by additional assays. Enah localizes at the leading edge
Table 1. List of Bait Peptides and the Identified Proteins.
Bait Prey
Protein Peptide
Binding motifs
(found in bait) Domains Identified proteinsw
Control AYGDLPFYVRSDGLRSHF None None
SOS1 VPPPVPPRRRPESAPAES PXXP SH3 Grb2, Itsn1, Pacsin1, Sh3kbp1, Cd2ap,
Amph
Stonin2 PWRATNPFLNETLQ NPF EH Eps15l1, Itsn1, Ehd3
Epsin1 GAKASNPFLPSGAP NPF PXXP EH SH3 Eps15l1, Itsn1, Amph
mGluR5 ELVALTPPSPFRDSVDS PPXXF PXXP EVH1 (class II) SH3 Homer1, Homer3
WAVE1 PQGEVQGLPPPPPPPPLP PXXP PPLP (F/L)PPPP SH3 WW EVH1 (class I) Vasp, Gas7, Enah, Amph
wProteins in italics were previously known to bind to the bait peptides and reproduced in the study. The interactions between proteins in bold italics and the bait
proteins were identified in the bioinformatics study.
doi:10.1371/journal.pone.0037035.t001
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Figure 3. PAX successfully identifies interacting proteins from tissue lysates. (A) Cluster analysis of MS/MS-identified proteins. Candidate
interactors with the bait peptides from SOS1, Stonin2, Epsin1 and mGluR5 were hierarchically clustered using unbiased Pearson correlation of the
mean normalized spectral counts. Protein clusters of single bait interactors are indicated with blue bars. (B) Identification of selective bait interactors.
Single bait interactors identified in (A) are exhibited. Proteins in brown are known to bind to the corresponding bait peptides. Bioinformatics analysis
Peptide Array Crosslinking for Proteomic Profiling
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revealed that proteins in orange were previously shown to interact with the bait proteins. (C) Protein interaction domain filtering. Proteins that
showed association to the control bait peptide were eliminated from the MS-identified proteins, and the rest was subjected to cluster analysis.
Subsequently, the proteins that contain domains anticipated to interact with consensus binding motifs found in bait peptides were selected as high
confidence interactors. (D) Identification of the interactors with anticipated peptide recognition domains. Proteins were colored as explained in (B).
doi:10.1371/journal.pone.0037035.g003
Figure 4. PAX identifies novel interacting proteins with WAVE1. (A) Identification of ligands for a WAVE1 derived peptide. MS/MS data for
WAVE1 trapped proteins from brain lysate were combined with those for control, SOS1, Stonin2, Epsin1 and mGluR5 and subjected to cluster analysis
as in Fig. 3A. Vasp and Gas7 are known to interact with other members of the WAVE/WASP family proteins. (B) Protein interaction domain filtering.
Enah and Amph, in addition to Vasp and Gas7, were identified as WAVE1 peptide-interacting proteins. (C) Only 3 of the 13 proteins identified in (B)
were identified as abundant proteins using label-free LC/MS/MS quantification of mouse brain lysates. (D) WAVE1 peptide interactome. PAX
identified high confidence interactions (red dotted arrows) with WAVE1. The previously known interactions are indicated with black arrows. The
WAVE1 selective binding proteins contain domains (shown in red) that are expected to interact with the WAVE1 polyproline peptide (see Table 1). (E–
F) Co-immunoprecipitation assays with full-length WAVE1 and (E) Amph or (F) Gas7. (G) GST pulldown of Enah using the proline peptide bait of
WAVE1. (H) Co-immunoprecipitation of GFP-Enah with full-length WAVE1 and WAVE1 lacking the bait proline peptide. (I) Physiological interaction
between WAVE1 and Enah. Reciprocal co-immunoprecipitation experiments were performed using rat brain extract (RBE). The precipitates were
analyzed by Western blotting. (J) Co-localization of WAVE1 and Enah in fibroblast cells. Immunostaining of endogenous WAVE1 showed co-
localization with Enah in MVD7 cells expressing GFP-tagged Enah.
doi:10.1371/journal.pone.0037035.g004
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of lamellipodia and the tip of fillopodia, which are protrusion
structures of the cell comprising highly branched or long and
unbranched actin filaments, respectively. Enah has been shown to
positively regulate filopodia formation in part by binding to and
protecting the fast growing barbed ends of actin filaments [37].
The WAVE/WASP family proteins faciliate the formation of
lamellipodia by initiating the Arp2/3-based branching of actin
filaments. These branched filaments may form the foundation for
subsequent filopodia formation, whose actin filaments emanate
from the lamellipodial structure [6,38]. A recent study has
revealed that WAVE2 forms a protein complex with Arp2/3
and mDia2, a formin-family protein that initiates and elongates
unbranched actin filaments by also binding to the barbed end of
filaments [39]. Binding of WAVE2 inhibits mDia2-mediated
filopodia formation, providing with an unexpected role for
WAVE2 in the inhibition of filopodia initiation. Our finding
suggests a new link between WAVE1 and the filopodia-regulatory
protein Enah. The exact functional relationship remains to be
resolved, but it is possible that Enah is released from WAVE1 to
protect newly nucleated filaments from capping, allowing them to
subsequently elongate.
The PAX methodology presented here has a several advan-
tages. Multiple baits can be synthesized on a single membrane and
these can be simultaneously incubated with a lysate to photo-trap
interacting proteins, thus enabling rapid, high-throughput experi-
ments for several peptide sequences. Photo activation-dependent
cross-linking also enables the potential trapping of protein
interactions within the context of various experimental schemes
such as lysates from stimulus or inhibitor treated cells or tissue.
Thus the experimental procedures can be flexibly designed
according to the types of expected ligands for each peptide bait.
PAX also has a broad potential utility; it is applicable to any cell or
tissue lysates but can also be used to identify organelle or
subcellular fraction-dependent protein interactions. The availabil-
ity of a broad range of modified amino acids and the ability to
incorporate them into synthetic bait peptides by SPOT technology
should provide interesting future applications for PAX, such as the
identification of post-translational modification-dependent protein
interactions. It should be noted, however, that additional
experimental validations are required, especially to ensure non-
native interactions are not induced by the incorporation of
unnatural amino acids. In summary, the PAX methodology
developed in this study presents a versatile proteomics tool with
a broad potential application for rapid peptide-protein interaction
discovery.
Materials and Methods
Antibodies
Rabbit polyclonal srGAP2, Enah and WAVE1 antibody have
been previously described [21,22,40]. Antibody against Homer1,
was purchased from BD Transduction. Horseradish peroxidase
(HRP)-conjugated and Alexa-labeled secondary antibodies were
purchased from GE Healthcare and Invitrogen, respectively. GFP-
trap agarose (ChromoTek) was used for anti-GFP immunopreci-
pitations. Anti-V5 epitope antibody was purchased from Invitro-
gen, Anti-Myc antibody clone 9E10 was purchased from
Millipore.
Plasmids
GFP-WAVE1, Flag-WAVE1, and Flag-WAVE1DPro were
previously described [21]. GFP-Mena and was obtained from
Frank Gertler (MIT) and Myc-Amph, was obtained from
Tadaomi Takenawa (Kobe Univ., Japan) and Hiroyuki Nakanishi
(Kumamoto Univ., Japan). Full length GAS7 cDNA (Accession
BC001152) was purchased from Open Biosystems. GST-Pro-
WAVE1 was constructed by cloning the coding sequence of
WAVE1 encompassing the peptide sequence
PQGEVQGLPPPPPPPPLP into the pGEX-4T1 vector (GE
healthcare Bio-Sciences).
Peptide Array Synthesis
Peptides (14–18 mer) were synthesized as previously described
[21] using Auto-Spot Robot ASP 222 (INTAVIS AG, Ko¨ln,
Germany) except that all the procedure was performed in the dark
to avoid undesirable photoactivation of pBpa.
Peptide Array X-linking (PAX)
For the PAX of srGAP2 to FMNL1 poly-proline peptide, the
following method was used. A 500 ml culture of FreeStyle 293 cells
(Invitrogen) was grown in FreeStyle 293 medium (Gibco) to the
density of 16106 cells/ml. Transfection was done using 500 mg of
full-length srGAP2 DNA as described previously [20]. After a 3-
day incubation at 37uC, the cells were pelleted, lysed in 10 ml of
ice-cold lysis buffer (25 mM HEPES pH7.4, 150 mM NaCl,
1 mM EDTA, 0.5% Triton X-100, 1 mM 4-(2-aminoethyl)ben-
zenesulfonyl fluoride hydrochloride (AEBSF), 2 mg/ml Leupeptin/
Pepstatin), homogenized with a Dounce homogenizer, and
subjected to centrifugation at 17,2006 g for 30 min. The
supernatant was further clarified by ultracentrifugation at
100,000 g for 1 hour. The supernatant was kept as cell lysate.
For the PAX of brain lysates, two frozen adult mouse brains (Pel-
Freez Biologicals) were crushed into small pieces using pestle and
mortar, resuspended in 20 ml of ice-cold lysis buffer, homogenized
with a Dounce homogenizer, and subjected to centrifugation at
17,2006 g for 30 min. The supernatant was kept as brain lysate.
The peptide array membrane shielded from light was incubated
for 2 h in a blocking buffer (5% nonfat dry milk, 1% bovine serum
albumin and 0.01% sodium azide in TBST (10 mM Tris pH7.5,
150 mM NaCl, 0.05% Tween-20)). After brief wash with TBST,
the membrane was incubated with the above brain lysate
overnight at 4uC and induced to cross-link under UV (365 nm)
for I h. Following a brief wash with TBST, the membrane was
washed 3 times of 15 min with a denaturing washing buffer (1.5%
Glycine pH2.5, 0.1% Tween-20, 1% SDS) at 95uC and 5 times of
3 min with water at room temperature, and kept at 4uC.
srGAP2 Dot Blot
GST-tagged srGAP2 antigen was purified from BL21 Escherichia
coli as described previously [41]. The dot blot of srGAP2 antigen was
made using S&S Manifold I dot-blot array system (Sigma-Aldrich).
Immunoblotting of the PAX Membrane
Following the PAX procedure, the peptide array membrane was
re-incubated in blocking buffer for 1 h. The membrane was then
cut and separated into individual bait strips and incubated with
primary antibodies in the blocking buffer for I h. After extensive
wash, the membrane was incubated with HRP-conjugated
secondary antibodies for 1 h, washed and developed using an
enhanced chemiluminescent substrate (Pierce).
Mass Spectrometric Analysis
Following the PAX procedure, the peptide array membrane was
cut and separated into bait strips. Each bait strip was further cut
into small pieces and place in a Protein LoBind tube (Eppendorf),
washed 36150 uL of 50 mM ammonium bicarbonate and
resuspended in 150 ml of 50 mM ammonium bicarbonate
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(pH8.0) containing 0.1% Rapigest (Waters, Milford MA). Samples
were reduced in 10 mM dithiolthreitol at 40 C for 20 min and
alkylated with iodoacetamide at 20 mM at room temperature for
40 min. On-membrane digestion was performed by adding
500 ng trypsin (Promega) and incubation at 37 C for 18 hr.
Polymer contamination, mostly polyethylene glycol, were removed
using ProteoSpin detergent removal spin-columns (Norgen Biotek,
ON Canada, product 10200) with a modified elution buffer
solution of 5% aqueous ammonia in 50 mM ammonium bi-
carbonate, pH 10.0). Peptides were brought to dryness using
vacuum centrifugation and then resuspended in 20 uL 5%
acetonitrile, 0.1% formic acid.5 uL of each sample was injected
onto a Waters nanoACQUITY UPLC equipped with a 1.7-mm
BEH130 C18 reversed-phase column [75 mm inside diameter
(ID)6250 mm]. The mobile phase consisted of (A) 0.1% formic
acid in water and (B) 0.1% formic acid in acetonitrile. Peptides
were trapped for 5 min on a 5-mm Symmetry C18 column
(180 mm ID620 mm) at 20 ml/min in 99.9% A. The analytical
column was then switched inline and a linear elution gradient of
5% B to 40% B was performed over 90 min at 300 nl/min. The
analytical column was connected to a fused silica PicoTip emitter
(New Objective) with a 10-mm tip orifice and coupled to the mass
spectrometer through an electrospray interface.
MS data were acquired on an LTQ-Orbitrap XL (Thermo
Scientific), mass spectrometer operating in positive-ion electro-
spray ionization mode. The instrument was set to acquire
a precursor MS scan in the Orbitrap from mass/charge ratio
(m/z) 400 to 2000 with r=60,000 at m/z 400 and a target AGC
setting of 16106 ions. In a data-dependent mode of acquisition,
MS/MS spectra of either the five most abundant precursor ions
were acquired in the Orbitrap at r=7500 at m/z 400 with a target
AGC setting of 26105 ions. Maximum fill times were set to
1000 ms for full MS scans and 500 ms for MS/MS scans with
minimum MS/MS triggering thresholds of 1000 counts. For all
experiments, fragmentation occurred in the LTQ linear ion trap
with a collision-induced dissociation (CID) energy setting of 35%
and a dynamic exclusion of 60 s was used for previously
fragmented precursor ions.
Qualitative Identifications from Raw LC-MS/MS Data
Raw LC-MS/MS data files were processed in Mascot distiller
(Matrix Science) and then submitted to independent Mascot
database searches (Matrix Science) against a Swissprot databases
(mus musculus taxonomy) containing both forward and reverse
entries of each protein. Search tolerances for LTQ-Orbitrap XL
data were 20 parts per million (ppm) for precursor ions and 0.04
dalton for product ions. System suitability tests of 50 fmol of yeast
alcohol dehydrogenase digest were run immediately before each
sample set. All data were searched using trypsin specificity with up
to two missed cleavages. Carbamidomethylation (+57.0214 daltons
on C) was set as a fixed modification, whereas oxidation (+15.9949
daltons on M) was considered a variable modification. All searched
spectra were imported into Scaffold (Proteome Software) and
annotated using a Bayesian statistical algorithm based on the
PeptideProphet and ProteinProphet algorithms, which yielded
a protein FDR of 2.9%. [42,43].
Label-Free Quantitation of Proteins from Mouse Brain
lysate
Label-free quantitation and integration of qualitative peptide
identifications was performed using Rosetta Elucidator (v 3.3,
Rosetta Inpharmatics, Seattle, WA). Triplicate LC-MS/MS anal-
ysis of mouse brain lysate were imported and subjected to
chromatographic retention time alignment using the PeakTellerH
algorithm.Quantitation of all detectable signals in the precursorMS
spectra was performed within Elucidator by calculating peak height
of the corresponding peptide level extracted ion chromatograms.
Protein quantities were calculated using the average MS response
from the two or three highest abundant peptides based on amodified
strategy initially described by Silva et. al. [44]. Absolute quantities
were determined by normalizingMS response factors to that of yeast
alcohol dehydrogenase spiked into the lysate at 50 fmol/ug.
Hierarchical Clustering
Relative protein abundance in the sample prepared by PAX
was quantified using spectral counting [45]. We used ‘‘quantitative
values’’ calculated within Scaffold to provide a first-pass normal-
ization of spectral counts for each protein based on the average
total spectra counts across multiple samples [46]. To further
normalize the relative protein abundance, the (modified) spectral
counts were expressed as a percentage of the total spectra observed
in the sample. Mean normalized spectral counts were obtained
from multiple independent experiments (n = 2 for each bait
peptide). Hierarchical clustering was performed based on the
uncentered Pearson correlation of the mean normalized spectral
counts using the Cluster 3.0 program (http://bonsai.ims.utokyo.
ac.jp/˜mdehoon/software/cluster/) [47]. The dendrograms were
viewed by the Java TreeView program (http://jtreeview.
sourceforge.net/) [48].
Bioinformatics Analysis
The known (physical) interactions were searched using Ingenuity
(http://www.ingenuity.com/), GeneMANIA (version 2.0) (http://
genemania.org/) and String (version 8.3) (http://string-db.org/)
[49].
Immunoprecipitation and Pull-down Experiments
Co-immunoprecipitation and pull-down experiments were
performed as previously described in detail [21,22]. Briefly, lysates
were pre-cleared before incubation with antibody and either
agarose conjugated protein-A or G overnight at 4 degrees C with
rocking. Antibodies and bound proteins from extracts were
precipitated by centrifugation and extensively washed. Bound
proteins were eluted in SDS sample buffer. For GST pull-down
assays, pre-cleared cell lysates were incubated with GST proteins
bound to glutathione-sepharose (GE Healthcare) followed by
washing, elution in sample buffer, and immunoblotting.
Immunostaining of Cultured Mouse Fibroblast Cells
MVD7 cells [40] expressing EGFP-Enah were maintained as
previously described. Cells were grown on a coated coverslip, fixed,
stained with anti-WAVE1 antibody and imaged as described [50].
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